$SRBK

SR Bancorp, Inc. (SRBK): Results of Operations and Financial Condition

SR Bancorp, Inc. (SRBK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_940088.htm EXHIBIT 99.1 ex_940088.htm Exhibit 99.1 FOR IMMEDIATE RELEASE Contact : Christopher J. Pribula President and Chief Executive Officer SR Bancorp, Inc. (732) 560-1700, ext. 5205 SR BANCORP, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS Bound

Original reporting
Published Jul 28, 2026, 8:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 8:02 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$SRBK
Neutral
medium confidence
Mentioned
$SRBK
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$SRBKNeutralMed
01

Why it matters

The filing updates investors on profitability (GAAP net income down YoY), credit performance (no charge-offs, modest provision), and interest-rate sensitivity (NIM and spread up) while showing balance sheet growth (loans and deposits up).

02

Market read

Traders can reassess near-term valuation drivers for a small community bank: earnings power versus one-time items, and whether NIM expansion persists alongside loan growth and funding costs.

03

What to watch

Net interest-earning assets fell $50.8m while NIM rose, implying balance sheet mix and funding dynamics matter; traders should also watch the direction of credit costs despite zero charge-offs and a slightly lower allowance ratio.

Relevance 7/10Novelty 6/10Timing: after-hours filing of FY2026/Q4 results on July 28, 2026

Background

This is an SEC Form 8-K (Item 2.02) with Exhibit 99.1 announcing SR Bancorp’s fourth quarter and full-year financial results for the year ended June 30, 2026.

Company-level read

Ticker impact

$SRBKNeutralMedium confidence
Context

SR Bancorp reported Q4 FY2026 net income of $940k, down from $2.2m a year ago, alongside loan and deposit growth at June 30, 2026.

Expected impact

Near-term trading likely choppy, with investors weighing lower GAAP earnings versus improving NIM and growth metrics.

Evidence & confidence

The filing provides concrete income statement and balance sheet datapoints (net income decline, NIM up 15 bps, loans up 13%, deposits up 9.5%) but no explicit forward guidance or capital/liquidity action.

Market effects

Regional bank read-through: margin expansion and deposit-funded loan growth can support sentiment, but earnings volatility remains a key risk signal.

Primarily impacts sentiment around small-cap community banking in its operating footprint, with limited broader macro spillover.

Low global relevance; effects are largely confined to US small-cap financials and local credit conditions.

Counterpoint

The GAAP net income decline may be largely driven by one-time items (life insurance gains and fair value accretion adjustments), so underlying operating profitability could be less deteriorated than headline earnings suggest.

Key entities

  • SR Bancorp, Inc.

    NASDAQ-listed holding company for Somerset Regal Bank; reported Q4 and full-year FY2026 results in the 8-K.

  • Somerset Regal Bank

    Operating bank subsidiary referenced as the company’s banking entity.

Related articles

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.

$GXOMed

GXO Logistics Q2 Earnings Call Highlights

GXO Logistics reported Q2 results and said it secured over $1 billion in expected incremental new-business revenue for 2026 and about $353 million for 2027. Management cited a $2.7 billion sales pipeline after quarter end. Operating cash flow was $76 million, free cash flow positive $12 million, cash $769 million, and net leverage 2.6x. GXO plans to target EBIT margins above 6% and deploy AI across ~50 sites in 2026.

$GRNDMed

Grindr Q2 Earnings Call Highlights

Grindr (NYSE:GRND) said free users remain central to its strategy, while AI tools are boosting engineering productivity. Management estimated engineering output rose about 2.5x from July 2025 to April 2026 with similar headcount, supporting a 39% to 42% adjusted EBITDA margin outlook. EDGE AI premium tier rollout is planned for later in fall; operating expenses ex cost of revenue were $71M vs $53M.

$HAEMedAI 8/10

Haemonetics Q1 Earnings Call Highlights

Haemonetics (NYSE:HAE) reported Q1 interventional technologies returning to 3% organic growth, with vascular closure led by VASCADE MVP and MVP XL momentum in the U.S. Apheresis revenue rose 6% organically to $191M and plasma revenue grew 8% organically as Persona PLUS rollout accelerates. Haemonetics raised FY2027 revenue guidance to 5% to 8% reported and 4% to 7% organic.